Guided Meditation to Decrease Perioperative Anxiety and Increase Patient Intraoperative Compliance in Vascular Surgery

NCT ID: NCT05837481

Last Updated: 2024-10-16

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-11

Study Completion Date

2024-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of this clinical trial is to test the feasibility of implementing a perioperative guided meditation program for patients undergoing peripheral vascular interventions that are performed under procedural sedation and analgesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, randomized, controlled study involving 30 adult patients undergoing peripheral vascular interventions. Patients will be randomized to two arms: an intervention arm where patients will participate in perioperative guided meditation, and a control arm where patients will receive standard of care without any meditation intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripheral Vascular Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Caregivers
The proceduralists that will be performing the peripheral vascular interventions will be blinded to the group allocation.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Meditation Group

Two sessions of guided meditation on the day of surgery, both to occur before the start of surgery

Group Type EXPERIMENTAL

Meditation

Intervention Type BEHAVIORAL

Guided meditation utilizing breath awareness, body scan and visualization techniques

Control Group

Standard of care, which does not involve any meditation programs

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Meditation

Guided meditation utilizing breath awareness, body scan and visualization techniques

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older
* Undergoing an endovascular procedure for peripheral vascular disease
* Anesthesia plan for procedural sedation and analgesia

Exclusion Criteria

* Pre-existing psychiatric disorder such as anxiety, panic disorder, depression, psychosis, or bipolar disorder
* Non-English speaking
* Prior history of ipsilateral lower extremity amputation
* Urgent or Emergent Surgery
* Anesthesia plan for general anesthesia
* Undergoing a hybrid procedure (simultaneous endovascular and open surgery)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Agency for Healthcare Research and Quality (AHRQ)

FED

Sponsor Role collaborator

Massachusetts General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Anahita Dua, MBCHB, MBA, MSC

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chien Yi M Png, MD

Role: STUDY_CHAIR

Massachusetts General Hospital

Chien Yi M Png, MD

Role: STUDY_DIRECTOR

Massachusetts General Hospital

Anahita Dua, MD

Role: PRINCIPAL_INVESTIGATOR

Massachusetts General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status

Newton Wellesley Hospital

Newton, Massachusetts, United States

Site Status

Salem Hospital

Salem, Massachusetts, United States

Site Status

Southern New Hampshire Hospital

Nashua, New Hampshire, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

F32HS028943-01

Identifier Type: AHRQ

Identifier Source: secondary_id

View Link

2021P002072

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.